• UroGen Pharma Ltd. (NASDAQ:URGN) Receives Consensus Rating of "Buy" from Brokerages

    Source: Buzz FX / 25 Jan 2025 01:41:17   America/Chicago


    UroGen Pharma Ltd. (NASDAQ:URGN) Receives Consensus Rating of "Buy" from Brokerages Written by MarketBeat January 25, 2025 Share Link copied to clipboard. Shares of UroGen Pharma Ltd. ( NASDAQ:URGN - Get Free Report ) have been given an ave
    Read more...
Share on,